In a study of 13 thymic carcinoma and 5 thymoma tumor samples from advanced, pre-treated TETs, the overexpression of WT1 was detected in 84.6% of thymic carcinomas and 80% of thymomas [36]. Here, WT1 is linked to thymoma.